Market Scope surveys physicians regarding procedure volumes, surgical techniques, and product use. We use this data, along with our extensive database of physicians and surgery centers, our wide-ranging knowledge of products and technology, and our comprehensive network of industry contacts, to regularly report on the ophthalmic and orthopedic industries.
Our report on the retinal pharmaceuticals and biologics market is in its ninth edition. It is a leading industry source for accurate and relevant information on all aspects of the market. We cover prevalence and forecasts for retinal diseases and conditions. We discuss therapeutic approaches and mechanisms of action under investigation. We discuss the market dynamics for currently commercialized products and the rich and crowded pipeline of investigational therapies. We review patient-based economic issues and reimbursement and analyze treatment patterns and trends. We also forecast product demand in units and dollars, and we analyze market shares by product category.
Our report on the glaucoma pharmaceuticals market, now in its fifth edition, is a leading industry source for accurate and relevant information on all aspects of the glaucoma pharmaceuticals market. The glaucoma pharmaceuticals market is one of the largest and most complex market segments in ophthalmology with a variety of drug classes, as well as proprietary and generic versions of many drugs. Current ocular hypotensive medication classes used to treat glaucoma were developed 20 years ago or more, and generic versions of these medications are now in widespread use.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.